Curaleaf, one of the biggest marijuana companies in the United States, is facing a lawsuit by an Idaho man who alleges that he unwittingly took THC-laced CBD drops.
The man said he took what he thought were CBD wellness drops but they had actually contained the psychoactive ingredient THC.
State regulators say the Oregon manufacturer Select, also known as Cura Cannabis, mixed up two lines of products at its Portland manufacturing site.
A CBD product was not supposed to contain THC, but bottles sold contained high levels of the psychoactive ingredient associated with marijuana. Another THC product had been sold without sufficient doses of THC. Both have been recalled.
The man’s suit appears to be the first against the company in the case.
“I was with some friends and started to disconnect from reality,” said Jason Crawforth, 51. “My body started shaking. I couldn’t stop my arms and legs from quivering. And my mind was disappearing.”
He said he purchased the drops last month in Oregon and first took them Sept. 3 while camping in Nevada.
Crawforth said he took another dose of Curaleaf’s brand of Select CBD drops the next day as he was unaware of the problrm. He said he had a similar reaction while driving a motorhome back to Idaho.
“If my friend wasn’t with me, I would have driven that motorhome off the road or crashed into a car coming the other way,” Crawforth said. He ended up spending hours in an emergency room, where doctors notified Crawforth that he had THC in his system.
The Oregon Liquor and Cannabis Commission said last week that Curaleaf’s production workers somehow mixed up its Select line of CBD drops.
“We are grateful to the OLCC and individuals who brought this serious matter to our attention,” Curaleaf said in a written statement. “We sincerely apologize to all customers impacted by this mistake.”
Curaleaf purchased Cura Cannabis, last year in an all-stock deal valued at $400 million.
